Digital AI technology: A game-changer for rare disease diagnosis AI technology isn’t designed to replace clinicians - its function is to help them.
News A glance back to Pharma Integrates 2022 – part i Run by Life Science Integrates, Pharma Integrates was in its eleventh year in 2022.
News NHS Confederation, ABPI report focuses on industry collabora... According to a joint report published today from the
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
